{"code":0,"message":"","data":{"typeDesc":"新闻快讯","releaseTime":"2026-04-15T15:49:07","createPsn":"陈小泉","firstColumnCode":"JSKX","collectFlag":0,"source":"经理人","title":"金陵药业：分公司金陵制药厂药品上市申请不予批准","type":"XW","likesFlag":0,"collectAmount":0,"content":"<p>【金陵药业：分公司金陵制药厂药品上市申请不予批准】</p><p>　　金陵药业公告，分公司金陵药业股份有限公司南京金陵制药厂收到国家药品监督管理局下发的《药品上市申请不予批准通知书》。药品名称为碳酸司维拉姆干混悬剂，主要用于控制正在接受透析治疗的慢性肾脏病(CKD)成人患者的高磷血症等的治疗。金陵制药厂于2025年4月向国家药品监督管理局提交药品上市许可申请并被受理。本次不予批准的原因为：现有资料不能支持该药品体外生物等效性结论。本次药品上市申请未获批准不会对公司当期业绩产生重大影响。</p>","downloadAmount":0,"filePageAmount":0,"releaseDateStr":"2026-04-15 15:49:07","fileUrl":"","readAmount":0,"columnCode":"","id":17835,"keyword":"","likesAmount":0,"statusDesc":"已上架","createPsnId":21,"firstColumnName":"即时快讯","updateTime":"2026-04-15 15:49:24","coverImgUrl":"","isExistFile":0,"createTime":"2026-04-15 15:49:24","authorName":"","isTop":0,"simpleContent":"","contentLength":0,"status":1,"columnName":null}}